Conventus Flower Orthopedics receives FDA clearance for nail fixation system

Medical technology company Conventus Flower Orthopedics has received FDA 510(k) clearance for its new Flex-Thread ulna intramedullary nail system. 

Advertisement

The ulna nails, set to launch in February 2023, are the newest addition to Conventus’ Flex-Thread portfolio. 

The Flex-Thread ulna nail is designed to fix fractures and osteotomies of the ulna. It is the first and only flexible ulna nail that will be available in a range of diameters and lengths. 

Conventus first launched its Flex-Thread platform in 2021 with a fibula nail system. 

“With over 650 cases utilizing our Flex-Thread distal fibula nail system, we have seen tremendous results and have been extremely pleased with the adoption of this unique technology. We expect the Flex-Thread ulna intramedullary nail system to be well received and a terrific option for fracture management in the upper extremity market segment,” Brad Niemann, CEO of Conventus, said in a Jan. 19 press release. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.